LKL International Bhd.
MMYX:LKL0.03
MYR
0.00
(0.00%)
ISIN
MYQ0182OO004
Return %
Stock
S&P 500
1Y
-33.33
14.20
3Y
-79.31
81.12
5Y
-97.08
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Lian Seng Ti
- Full Time Employees
- 250
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Seri Kembangan Malaysia
- IPO Date
- May 16, 2016
- Website
- lklbeds.com
- Similar Companies
- Business
- LKL International Bhd. is a Malaysia-based investment holding company primarily engaged in the design, manufacturing, trading, and distribution of medical furniture, healthcare equipment, and medical peripherals, as well as retail pharmacy operations. Founded in 1993 and headquartered in Seri Kembangan, Selangor, Malaysia, the company operates across three principal business segments: Manufacturing, Trading, and Retail. Through its flagship operating subsidiary, LKL Advance Metaltech Sdn Bhd, the company produces and distributes a comprehensive portfolio of medical equipment and clinical furnishings, including electrical, hydraulic, and manual patient hospital beds for intensive care units (ICU), critical care units (CCU), geriatric care, and general medical wards; medical examination, treatment, and obstetrical delivery tables; emergency patient transport trolleys and stretcher systems; stainless steel instrument, dressing, and medication carts; infant nursery equipment and hospital bassinets; specialized medical chairs, blood donor couches, and dialysis recliners; and clinical peripherals, overbed tables, bedside lockers, and ward accessories. Under its trading operations, the group distributes third-party medical devices, specialized diagnostic machinery, patient care consumables, and personal protective equipment, while its retail division operates community pharmacy outlets offering pharmaceutical drugs, health supplements, personal care goods, and home healthcare aids. The company serves public and private hospitals, healthcare centers, clinics, nursing homes, and residential care institutions in Malaysia and exports to over 45 countries across Southeast Asia, Europe, the Middle East, Africa, and Central America. In recent developments, LKL International has advanced its regional expansion and corporate restructuring initiatives. In late 2024, the company formed a joint venture with PT Fasilitas Teknologi Nusantara to establish PT LKL Indonesia Makmur, expanding its manufacturing and distribution footprint into the Indonesian healthcare market, alongside the incorporation of a wholly-owned trading subsidiary, LandB Protrade Sdn Bhd. Additionally, in 2026, the group completed a capital reduction exercise of RM120 million to write off accumulated losses and rationalize its balance sheet, enhancing its equity base to support long-term operational growth.